The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Medical Progress
PreviousPrevious
Volume 340:438-447 February 11, 1999 Number 6
NextNext

Transfusion Medicine — Blood Transfusion— First of Two Parts
Lawrence T. Goodnough, M.D., Mark E. Brecher, M.D., Michael H. Kanter, M.D., and James P. AuBuchon, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Commentary
-Editorial
 by Ely, E. W.
-Letters
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Goodnough, L. T.
-PubMed Citation
Blood transfusion and blood conservation (techniques or strategies to avoid the need for blood) are complementary activities that constitute the clinical arena of transfusion medicine. Recent improvements in the safety of the blood supply and the increasing costs associated with transfusion therapies have led to a reevaluation of the clinical practices of blood transfusion and blood conservation. Among the issues that have been reevaluated are the threshold for transfusion at which the benefits outweigh the risks and the identification of patients most likely to benefit from blood conservation. This review summarizes recent developments in transfusion medicine that have affected the . . . [Full Text of this Article]

Trends in Blood Use and Collection

Risks of Blood Transfusion

Transmission of HIV

Transmission of HBV and HBC

Transmission of Other Viruses

Hemolytic Reactions

Contamination of Red Cells

Contamination of Platelets

Transfusion-Related Acute Lung Injury

Transfusion-Mediated Immunomodulation

Indications for Transfusion

Utilization Review

Intensive Care

Surgery

Guidelines for Transfusion

Conclusions


Source Information

From the Departments of Medicine and Pathology, Washington University School of Medicine, St. Louis (L.T.G.); the Departments of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill (M.E.B.); the Department of Pathology, Southern California Permanente Medical Group, Woodland Hills, Calif. (M.H.K.); and the Department of Pathology, Dartmouth–Hitchcock Medical Center, Lebanon, N.H. (J.P.A.).

Address reprint requests to Dr. Goodnough at Washington University School of Medicine, Division of Laboratory Medicine, Box 8118, 660 S. Euclid Ave., St. Louis, MO 63110-1093.

References


Related Letters:

Transfusion Medicine
Valeri C. R., Pivacek L. E., Crowley J. P., Vandenberghe P., Peerlinck K., Popovsky M. A., Kelly J. S., Prielipp R. C., Goodnough L. T., Brecher M. E., Kanter M. H., AuBuchon J. P.
Extract | Full Text  
N Engl J Med 1999; 341:124-127, Jul 8, 1999. Correspondence

Hypotensive Transfusion Reactions in Patients Taking Angiotensin-Converting–Enzyme Inhibitors
Quillen K.
Extract | Full Text  
N Engl J Med 2000; 343:1422-1423, Nov 9, 2000. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.